PGNY · XBRL financial data

Progyny financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (PGNY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	345	501	787	1,089	1,167	1,289
Cost of goods and services sold	275	388	620	850	914	984
Gross profit	70	112	167	239	253	304
Research and development	—	—	—	—	—	10
General and administrative	47	60	98	117	122	147
Total operating expenses	62	80	144	177	186	219
Operating income (loss)	8	32	23	62	67	85
Other income (expense)	0	(0)	0	5	16	10
Income tax expense (benefit)	(38)	(33)	(6)	9	29	37
Net income (loss)	46	66	30	62	54	59
Earnings per share, basic USD per share	0.54	0.74	0.33	0.65	0.59	0.68
Earnings per share, diluted USD per share	0.47	0.66	0.30	0.62	0.57	0.65
Weighted average shares, basic millions of shares	86	89	92	95	91	86
Weighted average shares, diluted millions of shares	99	100	100	101	95	90

Fiscal years (PGNY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	70	91	120	97	162	112
Marketable securities	39	28	69	274	66	198
Accounts receivable	76	135	240	242	235	220
Prepaid and other current assets	5	5	4	27	9	21
Total current assets	190	259	434	640	473	552
Property and equipment, net	3	5	8	10	12	30
Right-of-use asset	9	8	7	18	17	25
Goodwill	12	12	12	12	16	20
Total assets	254	358	543	757	607	742
Accounts payable	44	61	109	125	95	124
Total current liabilities	78	99	160	186	169	202
Lease liability, non-current	8	7	6	17	16	24
Total liabilities	87	106	166	203	185	226
Retained earnings (accumulated deficit)	(68)	(2)	28	90	144	203
Total stockholders' equity	167	252	377	553	422	516
Total liabilities and equity	254	358	543	757	607	742
Common shares outstanding (cover page) millions of shares	87	91	93	96	85	82

Fiscal years (PGNY's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	46	66	30	62	54	59
Stock-based compensation	13	34	101	123	128	132
Depreciation and amortization	2	1	2	2	3	5
Net cash from operating activities	36	26	80	189	179	210
Purchases of property and equipment	1	2	3	4	5	18
Net cash from investing activities	(40)	9	(44)	(201)	196	(159)
Share repurchases	—	—	0	0	300	82
Net cash from financing activities	(6)	(14)	(8)	(11)	(310)	(99)
Net change in cash	(10)	21	29	(23)	65	(48)

SIC 8090 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Progyny	117	341	57*	73.6M	Q3 FY26 10-QSep 30, 2026
Acadia Healthcare Company	163	895	98*	93.0M	Q3 FY26 10-QSep 30, 2026
Sotera Health	412	325	111*	285.6M	Q3 FY26 10-QSep 30, 2026
Concentra Group Holdings Parent	86	622	52*	126.5M	Q3 FY26 10-QSep 30, 2026
agilon health	174	1,519	50*	16.8M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 5:57 PM ET. The filing on SEC.gov is the record.